publication venue for
- Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer. 42:56-59. 2019
- A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer. 33:609-613. 2010
- The Contents and Readability of Informed Consent Forms for Oncology Clinical Trials. 33:387-392. 2010
- Adenoid Cystic Breast Carcinoma. 33:28-31. 2010
- Neuroendocrine Tumors of the Gastrointestinal Tract. 31:64-70. 2008
- The Influence of Mentorship on Research Productivity in Oncology. 30:549-555. 2007
- Natural History and Chemotherapy Effectiveness for Advanced Adenocarcinoma of the Small Bowel: A Retrospective Review of 113 Cases. 29:225-231. 2006
- A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases. 28:547-554. 2005
- Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer. 27:172-177. 2004
- Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints. 25:S10-S18. 2002
- Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.. 25:S10-S18. 2002
- Introduction. 14:vii-vii. 1991
- THERAPEUTIC ADVANTAGES OF DROLOXIFENE, A NEW ANTIESTROGEN, IN BREAST-CANCER - PROCEEDINGS OF THE SATELLITE SYMPOSIUM DROLOXIFENE, A NEW ANTIESTROGEN WITH THERAPEUTIC ADVANTAGES HELD DURING THE 15TH INTERNATIONAL CANCER CONGRESS, HAMBURG, FRG, AUGUST 18, 1990 - SUMMARY. 14:S62-S63. 1991
- Introduction 2015
- Angiosarcomas of the Breast 2007
- Summary 1991
- A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE BREAST-CANCER 1984